Stay updated on Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.

Latest updates to the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedNew locations added: Ho Chi Minh City (Vietnam), Edinburgh (UK), Maumee (Ohio), Ann Arbor (Michigan), and Tainan (Taiwan). Total sites increased from 260 to 264, with the Tainan site previously removed and later re-added.SummaryDifference0.4%

- Check21 days agoChange DetectedRemoved the previous state/province location listings and introduced a consolidated Locations section, adding new sites including Gurgaon, India, and locations across the US and Canada.SummaryDifference0.8%

- Check28 days agoChange DetectedAdded Gūrgaon, India, 122001 and removed Gurgaon, India, 122001, reflecting a minor localization change in the site list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check35 days agoNo Change Detected
- Check43 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2. The study details, contacts, locations, and other page content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1 on the page, a minor metadata change with no visible content updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check57 days agoChange DetectedAdded a study site in Tainan, Taiwan and updated the location label from Tainan City, Taiwan to Tainan. Removed the generic government funding notice text from the page.SummaryDifference0.1%

Stay in the know with updates to Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.